Alpha Cognition Announces European Patent Grant For Crystalline Benzgalantamine, ZUNVEYL's Active Ingredient, With Potential Protection Into 2042

Loading news article.

Alpha Cognition Announces European Patent Grant For Crystalline Benzgalantamine, ZUNVEYL's Active Ingredient, With Potential Protection Into 2042 | WAPE

Alpha Cognition Announces European Patent Grant For Crystalline Benzgalantamine, ZUNVEYL's Active Ingredient, With Potential Protection Into 2042

Article summary

Related companies

Comments —